The future of Apple Watch sales could be impacted by looming legal decisions in the ongoing patent dispute between Apple and medical device company, Masimo. The dispute pertains to the blood oxygen monitor feature in the Apple Watch, a selling point of recent models. While these devices are currently available on the market, forthcoming legal rulings could force Apple to temporarily halt sales or mandate modifications to the device.
Renowned for its diverse suite of health-tracking functions, the Apple Watch’s blood oxygen monitor has been a major draw for consumers interested in advanced health monitoring capabilities. In this tussle between two tech giants, it is this feature that lies at the center of contention.
If upcoming legal decisions swing in favor of Masimo, the immediate and future offerings of the Apple Watch could change drastically. This case exemplifies the delicate dance between tech innovation and intellectual property rights, a balancing act that has profound implications on product development, and by extension, market availability.
For further details and developments on this ongoing patent dispute, visit the original article on Law360.